Back to search
FDAFDA · Food and drugs·Recall number D-0034-2021

Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured by Hi-Tech Pharmacal Co Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01

Published October 21, 2020 · Recall initiated: September 24, 2020

Summary

FDA records drug Class III recall D-0034-2021, published October 21, 2020 and initiated September 24, 2020. Recalling firm: Leadiant Biosciences, Inc.; Status: Terminated; Reported quantity: 1380 bottles; Lot: Lot #: 370655, Exp. 10/31/2020. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.

What to do

Voluntary: Firm initiated · Letter

Get an email if CYSTARAN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CYSTARAN
Manufacturer
Leadiant Biosciences, Inc.
Distributor
PA and Italy
Lot
Lot #: 370655, Exp. 10/31/2020
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cystaran (cysteamine ophthalmic solution) 0.44%, For Ophthalmic Use Only, 15 mL bottle, Sterile, Rx Only, Manufactured by Hi-Tech Pharmacal Co Inc., Amityville, NY 11701 for Leadiant Biosciences, Inc., Gaithersburg, MD 20878, NDC 54482-020-01 recalled?

Yes. FDA published recall D-0034-2021 on October 21, 2020. Reported hazard: Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CYSTARAN.